Cassava Sciences Inc (SAVA)
23.12
+1.56
(+7.24%)
USD |
NASDAQ |
May 17, 16:00
23.14
+0.02
(+0.09%)
After-Hours: 20:00
Cassava Sciences Accounts Payable (Quarterly): 9.603M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 9.603M |
December 31, 2023 | 10.57M |
September 30, 2023 | 9.492M |
June 30, 2023 | 10.34M |
March 31, 2023 | 8.242M |
December 31, 2022 | 4.017M |
September 30, 2022 | 3.534M |
June 30, 2022 | 4.758M |
March 31, 2022 | 3.332M |
December 31, 2021 | 7.126M |
September 30, 2021 | 2.345M |
June 30, 2021 | 1.912M |
March 31, 2021 | 0.864M |
December 31, 2020 | 0.911M |
September 30, 2020 | 0.465M |
June 30, 2020 | 0.416M |
March 31, 2020 | 0.608M |
December 31, 2019 | 0.453M |
September 30, 2019 | 0.34M |
June 30, 2019 | 0.594M |
March 31, 2019 | 0.495M |
December 31, 2018 | 0.294M |
September 30, 2018 | 0.549M |
June 30, 2018 | 0.962M |
March 31, 2018 | 0.421M |
Date | Value |
---|---|
December 31, 2017 | 0.424M |
September 30, 2017 | 0.712M |
June 30, 2017 | 0.658M |
March 31, 2017 | 0.573M |
December 31, 2016 | 0.303M |
September 30, 2016 | 1.083M |
June 30, 2016 | 0.378M |
March 31, 2016 | 1.043M |
December 31, 2015 | 1.034M |
September 30, 2015 | 0.898M |
June 30, 2015 | 0.465M |
March 31, 2015 | 0.255M |
December 31, 2014 | 0.173M |
September 30, 2014 | 0.822M |
June 30, 2014 | 0.36M |
March 31, 2014 | 0.428M |
December 31, 2013 | 0.445M |
September 30, 2013 | 0.531M |
June 30, 2013 | 0.435M |
March 31, 2013 | 0.366M |
December 31, 2012 | 0.361M |
September 30, 2012 | 0.507M |
June 30, 2012 | 0.501M |
March 31, 2012 | 0.502M |
December 31, 2011 | 0.464M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.34M
Minimum
Sep 2019
10.57M
Maximum
Dec 2023
3.996M
Average
2.838M
Median
Accounts Payable (Quarterly) Benchmarks
Amylyx Pharmaceuticals Inc | 21.45M |
ACADIA Pharmaceuticals Inc | 19.33M |
Vertex Pharmaceuticals Inc | 351.40M |
Cormedix Inc | 2.826M |
Oragenics Inc | 1.245M |